Current State of Systemic Therapies for Advanced Renal Cell Carcinoma von Gulati, Shuchi, Vaishampayan, Ulka

Volltext

Nivolumab for Metastatic Renal Cell Carcinoma: Results of a Randomized Phase II Trial von Motzer, Robert J, Rini, Brian I, McDermott, David F, Redman, Bruce G, Kuzel, Timothy M, Harrison, Michael R, Vaishampayan, Ulka N, Drabkin, Harry A, George, Saby, Logan, Theodore F, Margolin, Kim A, Plimack, Elizabeth R, Lambert, Alexandre M, Waxman, Ian M, Hammers, Hans J

Volltext

External validation and comparison with other models of the International Metastatic Renal-Cell Carcinoma Database Consortium prognostic model: a population-based study von Heng, Daniel YC, Dr, Xie, Wanling, MS, Regan, Meredith M, ScD, Harshman, Lauren C, MD, Bjarnason, Georg A, MD, Vaishampayan, Ulka N, MD, Mackenzie, Mary, MD, Wood, Lori, MD, Donskov, Frede, MD, Tan, Min-Han, MD, Rha, Sun-Young, MD, Agarwal, Neeraj, MD, Kollmannsberger, Christian, MD, Rini, Brian I, Prof, Choueiri, Toni K, MD

Volltext

Everolimus versus sunitinib for patients with metastatic non-clear cell renal cell carcinoma (ASPEN): a multicentre, open-label, randomised phase 2 trial von Armstrong, Andrew J, Dr, Halabi, Susan, Prof, Eisen, Tim, Prof, Broderick, Samuel, MS, Stadler, Walter M, Prof, Jones, Robert J, Prof, Garcia, Jorge A, MD, Vaishampayan, Ulka N, Prof, Picus, Joel, Prof, Hawkins, Robert E, Prof, Hainsworth, John D, Prof, Kollmannsberger, Christian K, Prof, Logan, Theodore F, Prof, Puzanov, Igor, MD, Pickering, Lisa M, MD, Ryan, Christopher W, MD, Protheroe, Andrew, MD, Lusk, Christine M, MPH, Oberg, Sadie, BS, George, Daniel J, Prof

Volltext

The International Metastatic Renal Cell Carcinoma Database Consortium model as a prognostic tool in patients with metastatic renal cell carcinoma previously treated with first-line... von Ko, Jenny J, MD, Xie, Wanling, MS, Kroeger, Nils, MD, Lee, Jae-lyun, MD, Rini, Brian I, MD, Knox, Jennifer J, MD, Bjarnason, Georg A, MD, Srinivas, Sandy, MD, Pal, Sumanta K, MD, Yuasa, Takeshi, MD, Smoragiewicz, Martin, MD, Donskov, Frede, MD, Kanesvaran, Ravindran, MD, Wood, Lori, MD, Ernst, D Scott, MD, Agarwal, Neeraj, MD, Vaishampayan, Ulka N, MD, Rha, Sun-young, MD, Choueiri, Toni K, MD, Heng, Daniel Y C, Dr

Volltext

Pembrolizumab for Treatment-Refractory Metastatic Castration-Resistant Prostate Cancer: Multicohort, Open-Label Phase II KEYNOTE-199 Study von Antonarakis, Emmanuel S., Piulats, Josep M., Gross-Goupil, Marine, Goh, Jeffrey, Ojamaa, Kristiina, Hoimes, Christopher J., Vaishampayan, Ulka, Berger, Ranaan, Sezer, Ahmet, Alanko, Tuomo, de Wit, Ronald, Li, Chunde, Omlin, Aurelius, Procopio, Giuseppe, Fukasawa, Satoshi, Tabata, Ken-ichi, Park, Se Hoon, Feyerabend, Susan, Drake, Charles G., Wu, Haiyan, Qiu, Ping, Kim, Jeri, Poehlein, Christian, de Bono, Johann Sebastian

Volltext

Impact of Bone and Liver Metastases on Patients with Renal Cell Carcinoma Treated with Targeted Therapy von McKay, Rana R, Kroeger, Nils, Xie, Wanling, Lee, Jae-Lyun, Knox, Jennifer J, Bjarnason, Georg A, MacKenzie, Mary J, Wood, Lori, Srinivas, Sandy, Vaishampayan, Ulka N, Rha, Sun-Young, Pal, Sumanta K, Donskov, Frede, Tantravahi, Srinivas K, Rini, Brian I, Heng, Daniel Y.C, Choueiri, Toni K

Volltext

Cabozantinib in Patients With Advanced Prostate Cancer: Results of a Phase II Randomized Discontinuation Trial von SMITH, David C, SMITH, Matthew R, VAISHAMPAYAN, Ulka N, HAAS, Naomi B, SPIRA, Alexander I, LARA, Primo N, LIN, Chia-Chi, SRINIVAS, Sandy, SELLA, Avishay, SCHÖFFSKI, Patrick, SCHEFFOLD, Christian, WEITZMAN, Aaron L, SWEENEY, Christopher, HUSSAIN, Maha, ELFIKY, Aymen A, LOGOTHETIS, Christopher, CORN, Paul G, VOGELZANG, Nicholas J, SMALL, Eric J, HARZSTARK, Andrea L, GORDON, Michael S

Volltext

Atezolizumab as first-line treatment in cisplatin-ineligible patients with locally advanced and metastatic urothelial carcinoma: a single-arm, multicentre, phase 2 trial von Balar, Arjun V, Dr, Galsky, Matthew D, MD, Rosenberg, Jonathan E, MD, Powles, Thomas, MD, Petrylak, Daniel P, MD, Bellmunt, Joaquim, MD, Loriot, Yohann, MD, Necchi, Andrea, MD, Hoffman-Censits, Jean, MD, Perez-Gracia, Jose Luis, MD, Dawson, Nancy A, MD, van der Heijden, Michiel S, MD, Dreicer, Robert, MD, Srinivas, Sandy, MD, Retz, Margitta M, MD, Joseph, Richard W, MD, Drakaki, Alexandra, MD, Vaishampayan, Ulka N, MD, Sridhar, Srikala S, MD, Quinn, David I, MD, Durán, Ignacio, MD, Shaffer, David R, MD, Eigl, Bernhard J, MD, Grivas, Petros D, MD, Yu, Evan Y, MD, Li, Shi, PhD, Kadel, Edward E, BS, Boyd, Zachary, MSc, Bourgon, Richard, PhD, Hegde, Priti S, PhD, Mariathasan, Sanjeev, PhD, Thåström, AnnChristine, PhD, Abidoye, Oyewale O, MD, Fine, Gregg D, MD, Bajorin, Dean F, MD

Volltext

First-line Immuno-Oncology Combination Therapies in Metastatic Renal-cell Carcinoma: Results from the International Metastatic Renal-cell Carcinoma Database Consortium von Dudani, Shaan, Graham, Jeffrey, Wells, J. Connor, Bakouny, Ziad, Pal, Sumanta K., Dizman, Nazli, Donskov, Frede, Porta, Camillo, de Velasco, Guillermo, Hansen, Aaron, Iafolla, Marco, Beuselinck, Benoit, Vaishampayan, Ulka N., Wood, Lori A., Liow, Elizabeth, Yan, Flora, Yuasa, Takeshi, Bjarnason, Georg A., Choueiri, Toni K., Heng, Daniel Y.C.

Volltext

Targeting SWI/SNF ATPases in enhancer-addicted prostate cancer von Xiao, Lanbo, Parolia, Abhijit, Qiao, Yuanyuan, Bawa, Pushpinder, Eyunni, Sanjana, Mannan, Rahul, Carson, Sandra E., Chang, Yu, Wang, Xiaoju, Zhang, Yuping, Vo, Josh N., Kregel, Steven, Simko, Stephanie A., Delekta, Andrew D., Jaber, Mustapha, Zheng, Heng, Apel, Ingrid J., McMurry, Lisa, Su, Fengyun, Wang, Rui, Zelenka-Wang, Sylvia, Sasmal, Sanjita, Khare, Leena, Mukherjee, Subhendu, Abbineni, Chandrasekhar, Aithal, Kiran, Bhakta, Mital S., Ghurye, Jay, Cao, Xuhong, Navone, Nora M., Nesvizhskii, Alexey I., Mehra, Rohit, Vaishampayan, Ulka, Blanchette, Marco, Wang, Yuzhuo, Samajdar, Susanta, Ramachandra, Murali, Chinnaiyan, Arul M.

Volltext

Satraplatin: leading the new generation of oral platinum agents von Bhargava, Ashish, Vaishampayan, Ulka N

Volltext

Comparative effectiveness of gemcitabine plus cisplatin versus methotrexate, vinblastine, doxorubicin, plus cisplatin as neoadjuvant therapy for muscle‐invasive bladder cancer von Galsky, Matthew D., Pal, Sumanta K., Chowdhury, Simon, Harshman, Lauren C., Crabb, Simon J., Wong, Yu‐Ning, Yu, Evan Y., Powles, Thomas, Moshier, Erin L., Ladoire, Sylvain, Hussain, Syed A., Agarwal, Neeraj, Vaishampayan, Ulka N., Recine, Federica, Berthold, Dominik, Necchi, Andrea, Theodore, Christine, Milowsky, Matthew I., Bellmunt, Joaquim, Rosenberg, Jonathan E.

Volltext

Niraparib in patients with metastatic castration-resistant prostate cancer and DNA repair gene defects (GALAHAD): a multicentre, open-label, phase 2 trial von Smith, Matthew R, Scher, Howard I, Sandhu, Shahneen, Efstathiou, Eleni, Lara, Primo N, Yu, Evan Y, Chi, Kim N, Ståhl, Olof, Olmos, David, Danila, Daniel C, Espina, Byron M, Zhao, Xin, Urtishak, Karen A, Francis, Peter, Lopez-Gitlitz, Angela, Parnis, Francis, Horvath, Lisa G., Steer, Christopher, Marx, Gavin, Sandhu, Shahneen, Ferguson, Thomas, Luyten, Daisy, Lumen, Nicolaas, Dirix, Luc, Goeminne, Jean-Charles, Gil, Thierry, Vulsteke, Christof, Kussumoto, Celio, Franke, Fabio A., Martinelli de Oliveira, Fabricio Augusto, Pereira de Santana Gomes, Andrea Juliana, Preto, Daniel D'Almeida, Zucca, Luis Eduardo, Borges, Giuliano Santos, Murad, Andre M., Saad, Fred, Chi, Kim N., Fradet, Yves, Fleshner, Neil E., Emmenegger, Urban, Brasso, Klaus, Culine, Stephane, Thiery-Vuillemin, Antoine, Joly, Florence, Fléchon, Aude, Hilgers, Werner, Borchiellini, Delphine, Barthélémy, Philippe, Berger, Raanan, Mermershtain, Wilmosh, Peer, Avivit, Sella, Avishay, Voortman, Johannes, Aarts, Maureen J., Gietema, Jourik A., Choi, Young-Deuk, Gafanov, Rustem A., Kopyltsov, Evgeniy, Carles, Joan, Mellado, Begoña, Maroto, José Pablo, García-Donás, Jesús, Rodríguez Moreno, Juan Francisco, Durán, Ignacio, Pérez-Valderrama, Begoña, Castro, Elena, Olmos, David, Méndez-Vidal, María José, Muñoz-Langa, José, Herranz, Urbano Anido, Puente Vázquez, Javier, Castellanos, Enrique, Hellström, Martin, Widmark, Anders, Lissbrant, Ingela Franck, Jellvert, Åsa, Külich, Cecilia, Blom, René, Kang, Chih-Hsiung, Ou, Yen-Chuan, Wang, Shian-Shiang, Attard, Gerhardt, Bahl, Amit, Kellati, Prasad, Parikh, Omi, Srinivasan, Rajaguru, Lester, Jason F., Staffurth, John N., Cheng, Heather H., Efstathiou, Eleni, Pilié, Patrick G., George, Daniel J., Karsh, Lawrence I., Kelly, W. Kevin, Danila, Daniel C., Smith, Matthew R., Heath, Elisabeth I., Vaishampayan, Ulka N., Emamekhoo, Hamid, Pinski, Jacek K.

Volltext

Characterization of metastatic urothelial carcinoma via comprehensive genomic profiling of circulating tumor DNA von Agarwal, Neeraj, Pal, Sumanta K., Hahn, Andrew W., Nussenzveig, Roberto H., Pond, Gregory R., Gupta, Sumati V., Wang, Jue, Bilen, Mehmet A., Naik, Gurudatta, Ghatalia, Pooja, Hoimes, Christopher J., Gopalakrishnan, Dharmesh, Barata, Pedro C., Drakaki, Alexandra, Faltas, Bishoy M., Kiedrowski, Lesli A., Lanman, Richard B., Nagy, Rebecca J., Vogelzang, Nicholas J., Boucher, Kenneth M., Vaishampayan, Ulka N., Sonpavde, Guru, Grivas, Petros

Volltext

Understanding Treatment Decisions and Management for Patients with Advanced Renal Cell Carcinoma Using Hypothetical Case Studies: A Vodcast von Garmezy, Benjamin, Vaishampayan, Ulka

Volltext

A Phase 1 study of RO6870810, a novel bromodomain and extra-terminal protein inhibitor, in patients with NUT carcinoma, other solid tumours, or diffuse large B-cell lymphoma von Shapiro, Geoffrey I., LoRusso, Patricia, Dowlati, Afshin, T. Do, Khanh, Jacobson, Caron A., Vaishampayan, Ulka, Weise, Amy, Caimi, Paolo F., Eder, Joseph Paul, French, Christopher A., Labriola-Tompkins, Emily, Boisserie, Frédéric, Pierceall, William E., Zhi, Jianguo, Passe, Sharon, DeMario, Mark, Kornacker, Martin, Armand, Philippe

Volltext

Cytoreductive Nephrectomy in Patients with Synchronous Metastases from Renal Cell Carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database Consortium von Heng, Daniel Y.C, Wells, J. Connor, Rini, Brian I, Beuselinck, Benoit, Lee, Jae-Lyun, Knox, Jennifer J, Bjarnason, Georg A, Pal, Sumanta Kumar, Kollmannsberger, Christian K, Yuasa, Takeshi, Srinivas, Sandy, Donskov, Frede, Bamias, Aristotelis, Wood, Lori A, Ernst, D. Scott, Agarwal, Neeraj, Vaishampayan, Ulka N, Rha, Sun Young, Kim, Jenny J, Choueiri, Toni K

Volltext

A Single-arm, Multicenter, Phase 2 Study of Lenvatinib Plus Everolimus in Patients with Advanced Non-Clear Cell Renal Cell Carcinoma von Hutson, Thomas E., Michaelson, M. Dror, Kuzel, Timothy M., Agarwal, Neeraj, Molina, Ana M., Hsieh, James J., Vaishampayan, Ulka N., Xie, Ran, Bapat, Urmi, Ye, Weifei, Jain, Rohit K., Fishman, Mayer N.

Volltext

Changing face of metastatic prostate cancer: the law of diminishing returns holds true von Vaishampayan, Ulka N

Volltext